Nanoparticle-Based Drug Delivery for Chronic Obstructive Pulmonary Disorder and Asthma

Wadhwa, R; Aggarwal, T; Thapliyal, N; Chellappan, DK; Gupta, G; Gulati, M; Collet, T; Oliver, B; Williams, K; Hansbro, PM; Dua, K; Maurya, PK

Nanoparticle-Based Drug Delivery for Chronic Obstructive Pulmonary Disorder and Asthma

Wadhwa, R Aggarwal, T Thapliyal, N Chellappan, DK Gupta, G Gulati, M Collet, T Oliver, B

Williams, K

Hansbro, PM

Dua, K

Maurya, PK

Permalink

Publisher:: Elsevier
Publication Type:: Chapter
Citation:: Nanotechnology in Modern Animal Biotechnology, 2019, pp. 59 - 73
Issue Date:: 2019

Closed Access

	Filename	Description	Size
	Nanotechnology_in_Modern_Animal_Biotechnology_Conc..._----_(5_-_Nanoparticle-Based_Drug_Delivery_for_Chronic_Obstructive_Pulmonary...).pdf	Published version	297.78 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Wadhwa, R	en_US
dc.contributor.author	Aggarwal, T	en_US
dc.contributor.author	Thapliyal, N	en_US
dc.contributor.author	Chellappan, DK	en_US
dc.contributor.author	Gupta, G	en_US
dc.contributor.author	Gulati, M	en_US
dc.contributor.author	Collet, T	en_US
dc.contributor.author	Oliver, B https://orcid.org/0000-0002-7122-9262	en_US
dc.contributor.author	Williams, K https://orcid.org/0000-0002-5094-243X	en_US
dc.contributor.author	Hansbro, PM https://orcid.org/0000-0002-4741-3035	en_US
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159	en_US
dc.contributor.author	Maurya, PK	en_US
dc.date.issued	2019	en_US
dc.identifier.citation	Nanotechnology in Modern Animal Biotechnology, 2019, pp. 59 - 73	en_US
dc.identifier.isbn	9780128188231	en_US
dc.identifier.uri	http://hdl.handle.net/10453/139161
dc.description.abstract	Pulmonary diseases including chronic obstructive pulmonary disease (COPD) and asthma affect millions of people all over the world. Conventional treatment methodologies are not sufficient to cure or prevent the disease. With the advent of nanotechnology, drug delivery to specific target site is still challenging, but targeted delivery can be achieved by physiochemical properties of the nanoparticles. Delivery of nanoparticles, liposomes, dendrimers, and others has been extensively studied for successful delivery by inhalation and aerosols. Several factors such as size, density, surface, and physical-chemical properties of nanoparticle are essential to cross airway barriers. In this chapter, different nanoparticle-mediated drug delivery systems have been highlighted along with their applications and toxicity in COPD and asthma.	en_US
dc.publisher	Elsevier	en_US
dc.relation	http://purl.org/au-research/grants/nhmrc/APP1175134
dc.relation.ispartof	Nanotechnology in Modern Animal Biotechnology	en_US
dc.relation.isbasedon	10.1016/b978-0-12-818823-1.00005-3	en_US
dc.title	Nanoparticle-Based Drug Delivery for Chronic Obstructive Pulmonary Disorder and Asthma	en_US
dc.type	Chapter
utslib.location	The Netherlands	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
pubs.organisational-group	/University of Technology Sydney/Strength - CHT - Health Technologies
pubs.organisational-group	/University of Technology Sydney/Students
utslib.copyright.status	closed_access
pubs.consider-herdc	false	en_US
pubs.place-of-publication	The Netherlands	en_US
pubs.publication-status	Published	en_US

Abstract:

Pulmonary diseases including chronic obstructive pulmonary disease (COPD) and asthma affect millions of people all over the world. Conventional treatment methodologies are not sufficient to cure or prevent the disease. With the advent of nanotechnology, drug delivery to specific target site is still challenging, but targeted delivery can be achieved by physiochemical properties of the nanoparticles. Delivery of nanoparticles, liposomes, dendrimers, and others has been extensively studied for successful delivery by inhalation and aerosols. Several factors such as size, density, surface, and physical-chemical properties of nanoparticle are essential to cross airway barriers. In this chapter, different nanoparticle-mediated drug delivery systems have been highlighted along with their applications and toxicity in COPD and asthma.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/139161